skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Current radiotherapeutic approaches to pancreatic cancer

Journal Article · · Cancer (Philadelphia); (United States)

Adenocarcinoma of the pancreas is not a radioresistant neoplasm, as was once believed. The data now suggest that in some instances this cancer may be radiocurable. This fact seems to justify the risk of pancreatic biopsy even in the face of unresectable disease, for it is well known that many benign conditions imitate pancreatic cancer. Clinical benefit from radiation for pancreatic cancer treatment is dose related. Careful delineation of tumor margins, precision treatment planning, and precision dose delivery can minimize damage to adjacent normal tissues. Interstitial implantation and intraoperative electron beam therapy are being studied as methods of accurate dose delivery for pancreatic cancer. Fractionation studies and high LET studies are in embryonic stages. Combined modality regimens may have much to offer in terms of improved palliation and survival for patients with localized adenocarcinoma of the pancreas.

OSTI ID:
5345250
Journal Information:
Cancer (Philadelphia); (United States), Vol. 47:6
Country of Publication:
United States
Language:
English

Similar Records

Clinical experiences with intraoperative radiotherapy of locally advanced cancers. [Demonstration of high cure rate and no side effects]
Journal Article · Tue Jan 01 00:00:00 EST 1980 · Cancer; (United States) · OSTI ID:5345250

Intraoperative electron beam irradiation for patients with unresectable pancreatic carcinoma
Journal Article · Sat Sep 01 00:00:00 EDT 1984 · Ann. Surg.; (United States) · OSTI ID:5345250

Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma
Journal Article · Tue Nov 15 00:00:00 EST 2005 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:5345250